[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Can-Am HIFU Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":56},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,38],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":4,"enrollmentInfo":16,"targetDuration":4,"studyType":19,"phases":4,"briefSummary":20,"conditions":21,"keywords":23,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":37},"100454714",false,"NCT05201131","Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).","Inclusion Criteria:\n\n* Male subjects of ≥ 18 years of age.\n* Primary diagnosis of Benign Prostate Hypertrophy (BPH).\n* Candidate for Rezūm therapy as per clinical decision of Investigator.\n* Willing and able to accurately complete the required questionnaires.\n* Willing and able to provide signed and dated informed consent\n\nExclusion Criteria:\n\n* Characteristics indicating a poor compliance with study protocol requirements.\n* Disease or other health condition that is not suitable for this study.\n* Unable or unwilling to provide signed informed consent.","MALE","18 Years",{"count":17,"type":18},50,"ESTIMATED","OBSERVATIONAL","To document the clinical outcome of Rezūm therapy for BPH patient in Canadian cohort.",[22],"Urologic Diseases",[24],"benigh prostate hypertrophy","RECRUITING","2022-01-07",{"date":28,"type":29},"2022-01-21","ACTUAL",{"date":31,"type":29},"2019-10-07",{"date":33,"type":18},"2026-12-31",{"name":35,"class":36},"Can-Am HIFU Inc.","OTHER",1,{"id":39,"slug":4,"hasResults":10,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":4,"eligibilityCriteria":43,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":4,"enrollmentInfo":44,"targetDuration":4,"studyType":19,"phases":4,"briefSummary":46,"conditions":47,"keywords":48,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":49,"lastUpdatePostDateStruct":50,"startDateStruct":52,"completionDateStruct":54,"leadSponsor":55,"locationsCount":37},"100452314","NCT05169892","Aquablation in Benign Prostatic Hyperplasia in Canada","Canadian Cohort of Aquablation, a Robotically Executed, Surgeon-guided, High-pressure Water Jet Ablation Therapy for Endoscopic Resection of Prostate Tissue, in Benign Prostatic Hyperplasia (BPH).","Inclusion Criteria:\n\n* Primary diagnosis of Benign Prostate Hypertrophy (BPH)\n* Male subjects of ≥ 18 years of age\n* Candidate for Aquablation therapy as per clinical decision of Investigator\n* Willing and able to accurately complete questionnaires\n* Willing and able to provide signed and dated informed consent\n\nExclusion Criteria:\n\n* Characteristics indicating a poor compliance with study protocol requirements.\n* Disease or other health condition that is not suitable for this study.\n* Unable or unwilling to provide signed informed consent.",{"count":45,"type":18},25,"To document the clinical outcome of Aquablation therapy for BPH patient in Canadian cohort.",[22],[24],"2021-12-09",{"date":51,"type":29},"2021-12-27",{"date":53,"type":29},"2019-10-09",{"date":33,"type":18},{"name":35,"class":36},""]